The DOI matches its Crossref record.
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Catecholamine levels are further increased by glucocorticoids, which block the transporters on glia that normally remove catecholamines from the extracellular space51.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 15
- Mark, A. J. Hypertension 14, 159–165 (1996).
- Schulteis, G. & Koob, G. Nature 371, 108–109 (1994). · DOI
- Brunner, H., Nelen, M., Breakefield, O., Ropers, H. & vanOost, B. Science 262, 578–580 (1993). · DOI · Paper page
- Pacholczyk, T., Blakely, R. & Amara, S. Nature 350, 350– 354 (1991). · DOI · Paper page
- Borowski, B. & Hoffman, B. Int. Rev. Neurobiol. 38, 139–199 (1995). · DOI
- Iversen, L. Br. J. Pharmacol. 25, 18–33 (1965).
- Trendelenburg, U. Handbook of Experimental Pharmacology Vol. 90 (eds Trendelenburg, U. & Weiner, N.) 279–319 (Springer, New York, 1988).
- Russ, H., Staudt, K., Martel, F., Gliese, M. & Schömig, E. Eur. J. Neurosci. 8, 1256– 1264 (1996). · DOI
- Karhunen, T., Tilgmann, C., Ulmanen, I., Julkunen, I. & Panula, P. J. Histochem. Cytochem. 42, 1079–1090 (1994). · DOI
- Eisenhofer, G., McCarty, R., Pacak, K., Russ, H. & Schömig, E. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 , 287–294 (1996). · DOI
- Gründemann, D. et al. J. Biol. Chem. 272, 10408– 10413 (1997). · DOI
- Schömig, E. et al. FEBS Lett. 425, 79– 86 (1998). · DOI
- Schömig, E. & Schönfeld, C.-L. Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 404–410 (1990). · DOI
- Iversen, L. Brit. J. Pharmacol. 24, 387–394 (1965).
- Luo, D.-F. et al. Am. J. Hum. Genet. 57, 911– 919 (1995).
Cited by
Sorted by citations
Items 101–200 of 350
Inazu, M., Takeda, H., & Matsumiya, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01566.x · Cited by 91
“3 kDa for deglycosylated EMT (Gründemann et al. 1998), which is very similar in size to the glial EMT protein described here (63 kDa).”
BackgroundMethodInfluentialOrganic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
Samodelov, S. L., Kullak-Ublick, G. A., Gai, Z., & Visentin, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217890 · Cited by 97
“The role of OCT3 in liver physiology is probably linked to the homeostasis of molecules that are not substrates of OCT1, such as the neurotransmitters adrenaline, noradrenaline, and histamine [14,73].”
BackgroundRole of organic cation transporters in drug-induced toxicity
Ciarimboli, G. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.547474 · Cited by 78
“(who identified it as the extraneuronal monoamine transporter) in Caki-1 cells (a human kidney carcinoma cell line) [17], by Kekuda et al.”
BackgroundCholine transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.
Inazu, M. (2014) · Biopharmaceutics & drug disposition · doi:10.1002/bdd.1892 · Cited by 86
“However, OCT3 does not recognize choline as a substrate [6–10].”
BackgroundJoyce, M. K. P., Uchendu, S., & Arnsten, A. F. T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.016 · Cited by 86
Martel, F., Monteiro, R., & Lemos, C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049668 · Cited by 83
Wagner, D. J., Hu, T., & Wang, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.002 · Cited by 93
“Oct3 was independently cloned from rat brain and placenta [35,36], while human OCT3 was cloned from Caki-1 cells and originally identified as an extraneuronal monoamine transporter [37].”
BackgroundMembrane Transporters as Mediators of Cisplatin Effects and Side Effects
Ciarimboli, G. (2012) · Scientifica · doi:10.6064/2012/473829 · Cited by 82
Volk, C., Gorboulev, V., Budiman, T., Nagel, G., & Koepsell, H. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1037 · Cited by 82
Wang, Y.-M., Xu, F., Gainetdinov, R. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00245-0 · Cited by 82
Baganz, N., Horton, R., Martin, K. P., Holmes, A., & Daws, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2740-10.2010 · Cited by 79
“…and consistent with a contribution to HPA axis-related impairment of 5-HT clearance, OCT3 is widely expressed in forebrain targets of glucocorticoids, including hippocampus (Gasser et al., 2009), and is functionally inhibited by corticosterone (Gründemann et al., 1998; Gasser et al., 2006).”
BackgroundKummer, W., Wiegand, S., Akinci, S., Wessler, I., Schinkel, A., Wess, J., Koepsell, H., Haberberger, R., & Lips, K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-65 · Cited by 79
“It also clears monoamines, including catecholamines and 5-HT, from the extracellular space [21], and hence its blockade is expected to increase the extracellular concentrations of these agents.”
BackgroundDatta, D., & Arnsten, A. (2019) · Brain Sciences · doi:10.3390/brainsci9050113 · Cited by 78
“Cortisol blocks extraneuronal catecholamine transporters, and thus expands the effects of catecholamines [80].”
BackgroundGenetic association studies of methamphetamine use disorders: A systematic review and synthesis
Bousman, C., Glatt, S., Everall, I., & Tsuang, M. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30936 · Cited by 77
“Finally, SLC22A3 encodes the organic cation transporter 3 (OCT3) which has been implicated in the transport and subsequent regulation of concentrations of METH as well as dopamine and serotonin in the brain [Grundemann et al., 1998; Wu et al., 1998].”
BackgroundStructural basis of organic cation transporter-3 inhibition
Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34284-8 · Cited by 77
Cano‐Soldado, P., & Pastor-Anglada, M. (2012) · Medicinal research reviews (Print) · doi:10.1002/med.20221 · Cited by 76
“Human OCT3 consists of 556 residues and shows a broad distribution with strong expression in liver, placenta, heart, and skeletal muscle.(86,87) In terms of subcellular localization, OCT1/3 have been localized to the sinusoidal (basolateral) membrane of hepatocytes in rat and human liver, OCT1-3 to the basolateral mem…”
BackgroundGrigat, S., Harlfinger, S., Pal, S., Striebinger, R., Golz, S., Geerts, A., Lazar, A., Schömig, E., & Gründemann, D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.015 · Cited by 72
Self-citationNongenomic actions of glucocorticosteroids on the airway vasculature in asthma.
Wanner, A., Horvath, G., Brieva, J., Kumar, S. D., & Mendes, E. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-013ms · Cited by 72
Saxton, S., Ryding, K., Aldous, R., Withers, S., Ohanian, J., & Heagerty, A. (2018) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310777 · Cited by 71
Role of organic cation transporters (OCTs) in the brain
Couroussé, T., & Gautron, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.008 · Cited by 81
Role of transporters in placental transfer of drugs.
Ganapathy, V., & Prasad, P. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.02.023 · Cited by 71
Quantitative Imaging in Live Human Cells Reveals Intracellular α1-Adrenoceptor Ligand-Binding Sites
Mackenzie, J. F., Daly, C., Pediani, J., & McGrath, J. C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39090-1 · Cited by 71
“The transporter responsible, the extraneuronal monamine transporter, formerly known as (Uptake2), has been cloned (Gründemann et al., 1998).”
Xenobiotic transporter expression and function in the human mammary gland
Ito, S., & Alcorn, J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00031-0 · Cited by 60
Wang, J. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.442 · Cited by 75
Friedrich, A., George, R. L., Bridges, C. C., Prasad, P., & Ganapathy, V. (2001) · Biochimica et Biophysica Acta · doi:10.1016/s0005-2736(01)00333-9 · Cited by 68
Neurobiological mechanisms that contribute to stress-related cocaine use
Mantsch, J. R., Vranjkovic, O., Twining, R. C., Gasser, P. J., McReynolds, J. R., & Blacktop, J. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.021 · Cited by 63
Zhou, F.-F., Zhu, L., Wang, K., & Murray, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.004 · Cited by 66
Horvath, G., Sutto, Z., Torbati, A., Conner, G., Salathe, M., & Wanner, A. (2003) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00054.2003 · Cited by 66
Lee, W.-K., Reichold, M., Edemir, B., Ciarimboli, G., Warth, R., Koepsell, H., & Thévenod, F. (2009) · AJP - Renal Physiology · doi:10.1152/ajprenal.90754.2008 · Cited by 65
Lozano, E., Herráez, E., Briz, O., Robledo, V., Hernandez-Iglesias, J., González-Hernández, A., & Marín, J. (2013) · BioMed Research International · doi:10.1155/2013/692071 · Cited by 64
“Type II includes a variety of cations, such as tetrapentylammonium [50, 79], decynium 22 [76], and disprocynium24 [80].”
BackgroundRiedemann, T., Patchev, A. V., Cho, K., & Almeida, O. F. X. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-2 · Cited by 65
“Additional file 1: Summary of rapid effects of corticosteroids and estrogens on the central nervous system [148-181].”
BackgroundBrain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling
Couroussé, T., Bacq, A., Belzung, C., Guiard, B. P., Balasse, L., Louis, F., Guisquet, A.-M. L., Gardier, A. M., Schinkel, A. H., Giros, B., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.86 · Cited by 62
Expression of the extraneuronal monoamine transporter in RPE and neural retina
Rajan, P., Kekuda, R., Chancy, C. D., Huang, W., Ganapathy, V., & Smith, S. L. (2000) · Current Eye Research · doi:10.1076/0271-3683(200003)2031-9ft195 · Cited by 56
Vialou, V., Balasse, L., Dumas, S., Giros, B., & Gautron, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.058 · Cited by 55
Zhu, H., Appel, D. I., Gründemann, D., Richelson, E., & Markowitz, J. S. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.01.008 · Cited by 54
Self-citationKouji, H., Inazu, M., Yamada, T., Tajima, H., Aoki, T., & Matsumiya, T. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.008 · Cited by 54
Feng, N., Mo, B., Johnson, P., Orchinik, M., Lowry, C. A., & Renner, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.016 · Cited by 54
Gene structures of the human non-neuronal monoamine transporters EMT and OCT2
Gründemann, D., & Schömig, E. (2000) · Human Genetics · doi:10.1007/s004390000309 · Cited by 54
Self-citationCholine and Its Products Acetylcholine and Phosphatidylcholine
Wurtman, R. J., Cansev, M., & Ulus, İ. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_18 · Cited by 45
Gasser, P. J., Hurley, M. M., Chan, J., & Pickel, V. M. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1315-9 · Cited by 52
“2004), and with its previously described role as a transporter mediating the uptake of extracellular monoamines (Grundemann et al. 1998).”
BackgroundInfluentialNuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.
Vaniotis, G., Allen, B., & Hébert, T. (2011) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00657.2011 · Cited by 52
“tissues including heart [(30, 43), reviewed in (54)], which”
The localisation of the extraneuronal monoamine transporter (EMT) in rat brain
Haag, C., Berkels, R., Gründemann, D., Lazar, A., Taubert, D., & Schömig, E. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02180.x · Cited by 52
“Functionally, it was long known as (uptake2) (Iversen and Salt 1965) and identified on a molecular basis in 1998 (Gründemann et al. 1998; Kekuda et al. 1998).”
BackgroundMethodInfluentialSelf-citationGPCRs in Intracellular Compartments: New Targets for Drug Discovery
Fasciani, I., Carli, M., Petragnano, F., Colaianni, F., Aloisi, G., Maggio, R., Scarselli, M., & Rossi, M. (2022) · Biomolecules · doi:10.3390/biom12101343 · Cited by 69
Lazar, A., Walitza, S., Jetter, A., Gerlach, M., Warnke, A., Herpertz-Dahlmann, B., Gründemann, D., Grimberg, G., Schulz, E., Remschmidt, H., et al. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007742 · Cited by 51
“…monoamine transporter (EMT) has been identified as the molecular correlate of the classical uptake system responsible for the non-neuronal inactivation of circulating and centrally released catecholamines, especially of norepinephrine and to a lesser extent of 5-HT (Gründemann et al., 1998).”
BackgroundInfluentialSelf-citationAssociation between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
Aoyama, N., Takahashi, N., Kitaichi, K., Ishihara, R., Saito, S., Maeno, N., Ji, X.-F., Takagi, K., Sekine, Y., Iyo, M., et al. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00004850-200607000-00095 · Cited by 51
Organic cation transporter mRNA and function in the rat superior cervical ganglion
Kristufek, D., Rudorfer, W., Pifl, C., & Huck, S. (2002) · Journal of Physiology · doi:10.1113/jphysiol.2002.021170 · Cited by 51
Horvath, G., Lieb, T., Conner, G., Salathe, M., & Wanner, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.4.4559 · Cited by 51
“We showed that: (1) NE uptake was time-dependent, with a time course expected for an uptake mechanism as shown by others (11, 12, 20, 31); (2) NE uptake rate was concentration-dependent, with an estimated Km value in the range of those previously published (25, 32, 33); and (3) a near-linear correlation exists between…”
BackgroundResultSerotonin in the Ventral Hippocampus Modulates Anxiety-Like Behavior during Amphetamine Withdrawal
Tu, W., Cook, A., Scholl, J., Mears, M., Watt, M., Renner, K., & Forster, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.019 · Cited by 48
“For instance, the OCT 3 is a polyspecific low-affinity but high-capacity transporter that functions in the clearance of cations including 5-HT (Grundemann et al., 1998; Koepsell et al., 2007; Daws, 2009), and is believed to contribute to the regulation of extracellular 5-HT especially when concentrations are elevated…”
Inazu, M., Yamada, T., Kubota, N., & Yamanaka, T. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.07.011 · Cited by 48
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A. M., & Guiard, B. P. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 55
“The uptake2 transporters, such as the extraneuronal monoamine transporters (EMT), display distinct pharmacological profiles compared to the monoamine uptake1 transporters and were identified several years after the monoamine uptake1 [50, 51].”
BackgroundRoozendaal, B., & Hermans, E. J. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2017.02.001 · Cited by 57
Rasmusson, A. M., Picciotto, M. R., & Krishnan‐Sarin, S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060193 · Cited by 49
Schildkraut, J., & Mooney, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.909 · Cited by 46
Koepsell, H. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0191 · Cited by 49
Nishijima, H., & Tomiyama, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00575 · Cited by 45
“Other than these high-affinity amine transporters, additional transporters for biogenic amines in the brain have been identified, such as OCT (Gründemann et al., 1998; Eisenhofer, 2001; Vialou et al., 2004; Amphoux et al., 2006; Koepsell et al., 2007) and PMAT (Engel et al., 2004; Engel and Wang,…”
BackgroundComparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone
Martel, F., Ribeiro, L., Calhau, C., & Azevedo, I. (1999) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005356 · Cited by 45
“…was recently shown that rOCT1 accepts the biogenic amines noradrenaline and dopamine as substrates (Busch et al. 1996; Breidert et al. 1997, 1998; Gründemann et al. 1998b), being most probably responsible for the transport of catecholamines from blood into cells in the kidney (Ullrich et al.…”
BackgroundMethodResultInfluentialAssessment of the 18F-Labeled PET Tracer LMI1195 for Imaging Norepinephrine Handling in Rat Hearts
Higuchi, T., Yousefi, B., Kaiser, F., Gärtner, F., Rischpler, C., Reder, S., Yu, M., Robinson, S., Schwaiger, M., & Nekolla, S. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104232 · Cited by 43
“Recently, the transporter OCT3 has been identified to be the mediator of the nonneural uptake-2 mechanism (29,30).”
BackgroundSolbach, T. F., Grube, M., Fromm, M. F., & Zolk, O. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182270783 · Cited by 40
Regulation of serotonin transporter gene expression in human glial cells by growth factors.
Kubota, N., Kiuchi, Y., Nemoto, M., Oyamada, H., Ohno, M., Funahashi, H., Shioda, S., & Oguchi, K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00906-2 · Cited by 42
Boukerb, A. M., Cambronel, M., Rodrigues, S., Mesguida, O., Knowlton, R., Feuilloley, M. G. J., Zommiti, M., & Connil, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.690942 · Cited by 47
Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue
Saxton, S. N., Withers, S., & Heagerty, A. M. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06862-4 · Cited by 57
Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A.
Kwok, B., Yamauchi, A., Rajesan, R., Chan, L., Dhillon, U., Gao, W., Xu, H., Wang, B., Takahashi, S., Semple, J., et al. (2006) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00087.2005 · Cited by 41
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
Lazar, A., Gründemann, D., Berkels, R., Taubert, D., Zimmermann, T., & Schömig, E. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0015-5 · Cited by 32
“Because of its functional profile and expression in sympathetically innervated tissues, EMT is a candidate gene for common disorders such as hypertension, obesity or neuropsychiatric diseases (Gründemann et al. 1998; Eisenhofer 2001).”
BackgroundSelf-citationInteraction of organic cation transporter 3 (SLC22A3) and amphetamine
Zhu, H.-J., Appel, D. I., Gründemann, D., & Markowitz, J. S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06738.x · Cited by 39
“The rank order of OCT3 transport efficiency towards these three neurotransmitters was determined to be NE > DA > 5-HT based on the ratios of Vmax to Km, which is likewise in agreement with other published investigations (Grundemann et al. 1998; Amphoux et al. 2006).”
BackgroundMethodResultInfluentialSelf-citationThe transport of organic cations in the small intestine: Current knowledge and emerging concepts
Kim, M.-K., & Shim, C. (2006) · Archives of pharmacal research · doi:10.1007/bf02969273 · Cited by 39
Martel, F., Calhau, C., & Azevedo, I. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000223 · Cited by 39
Emotion-induced retrograde amnesia varies as a function of noradrenergic-glucocorticoid activity
Hurlemann, R., Matusch, A., Hawellek, B., Klingmüller, D., Kölsch, H., Maier, W., & Dolan, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0836-6 · Cited by 38
Inazu, M., Takeda, H., Ikoshi, H., Uchida, Y., Kubota, N., Kiuchi, Y., Oguchi, K., & Matsumiya, T. (1999) · Neurosciences research · doi:10.1016/s0168-0102(99)00053-x · Cited by 38
Geissler, C. F., Friehs, M. A., Frings, C., & Domes, G. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105998 · Cited by 44
Hucke, A., & Ciarimboli, G. (2016) · Journal of clinical pharmacology · doi:10.1002/jcph.706 · Cited by 36
Natural and synthetic corticosteroids inhibit uptake2-mediated transport in CNS neurons
Hill, J. E., Makky, K., Shrestha, L., Hillard, C. J., & Gasser, P. J. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.11.012 · Cited by 37
“As shown in Figure 1, mRNAs for OCT1, OCT3, and PMAT were clearly detected in CGNs, while mRNA for SERT was detected at very low levels, and mRNAs for OCT2, DAT, and NET were not detected.”
InfluentialFujita, T., Shimada, A., Okada, N., & Yamamoto, A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.069 · Cited by 36
Haenisch, B., & Bönisch, H. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0479-8 · Cited by 36
Roles for the uptake2 transporter OCT3 in regulation of dopaminergic neurotransmission and behavior
Gasser, P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.008 · Cited by 35
Gasser, P. J., & Lowry, C. A. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.05.003 · Cited by 40
Bayer, M., Kuçi, Z., Schömig, E., Gründemann, D., Dittmann, H., Handgretinger, R., & Bruchelt, G. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.010 · Cited by 34
Self-citationCB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus
Scerif, M., Füzesi, T., Thomas, J., Kola, B., Grossman, A. B., Fekete, C., & Korbonits, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0192 · Cited by 36
“One possible explanation for the CB1-independent stimulatory effect of glucocorticoids on cardiac AMPK is the inhibitory effect of glucocorticoids on noradrenaline reuptake in the heart (Grundemann et al. 1998).”
BackgroundArnsten, A. F. T., Woo, E., Yang, S., Wang, M., & Datta, D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.003 · Cited by 35
“Glucocorticoids are known to block the extraneuronal catecholamine transporters on glia that normally serve to remove catecholamines from the extracellular space (60), which would exacerbate the stress response.”
General Overview of Organic Cation Transporters in Brain
Koepsell, H. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_449 · Cited by 42
Mulgaonkar, A., Venitz, J., Gründemann, D., & Sweet, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02289-12 · Cited by 32
“Previous work found hOCT1-mediated TEA accumulation in HEK293 cells to be linear with time through at least 2 min and reported a Michaelis-Menten constant (Km) value of 229 M for TEA (10, 25), and we obtained similar results in our laboratory (Km 296 34 M).”
MethodResultSelf-citationFunctional map of TEA transport activity in isolated rabbit renal proximal tubules.
Wright, S., Evans, K., Zhang, X., Cherrington, N., Sitar, D., & Dantzler, W. (2004) · AJP - Renal Physiology · doi:10.1152/ajprenal.00115.2004 · Cited by 32
Volk, C. (2014) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.100 · Cited by 32
Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy
Dina, O. A., Khasar, S. G., Alessandri‐Haber, N., Bogen, O., Chen, X., Green, P. G., Reichling, D. B., Messing, R. O., & Levine, J. D. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06425.x · Cited by 32
“Of note in this regard, NET expression is regulated by a variety of signals (Paczkowski et al., 1996; Jahng et al., 1998; Zahniser & Doolen, 2001; Hara et al., 2002; Mao et al., 2005; Habecker et al., 2006), including glucocorticoids (Grundemann et al., 1998; Eisenhofer, 2001).”
BackgroundNakayama, H., Kitaichi, K., Ito, Y., Hashimoto, K., Takagi, K., Yokoi, T., Takagi, K., Ozaki, N., Yamamoto, T., & Hasegawa, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.072 · Cited by 28
“OCT3 is expressed in several tissues including the placenta, intestine, heart and brain, and transporter (Grundemann et al., 1997, 1998; Kekuda et al., 1998).”
BackgroundRasmusson, A. M., Wu, R., Paliwal, P., Anderson, G. M., & Krishnan‐Sarin, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0367-6 · Cited by 33
“Both cross the blood– brain barrier (Compagnone and Mellon 2000) and exert, by direct action or the activity of metabolites (Rose et al. 1997; Grundemann et al. 1998; Morfin and Starka 2001), important metabolic, neuromodulatory, neurogenetic, and epigenetic effects in the brain (Kimonides et al.…”
BackgroundOsmotic swelling-provoked release of organic osmolytes in human intestinal epithelial cells
Tomassen, S. F. B., Fekkes, D., de Jonge, H. R., & Tilly, B. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00468.2003 · Cited by 29
Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
Gebauer, L., Jensen, O., Brockmöller, J., & Dücker, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01075 · Cited by 30
Pan, X., Wang, L., Gründemann, D., & Sweet, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01255-13 · Cited by 30
Self-citationNguyen, H. T., Guiard, B. P., Bacq, A., David, D. J. P., Mendez‐David, I., Quesseveur, G., Gautron, S., Sánchez, C., & Gardier, A. M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01850.x · Cited by 38
Taguchi, C., Inazu, M., Saiki, I., Yara, M., Hara, N., Yamanaka, T., & Uchino, H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.033 · Cited by 29
Hill, J. E., & Gasser, P. J. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.04.007 · Cited by 27
“Interestingly, OCT3-mediated transport is directly and acutely inhibited by the stress hormone corticosterone (Grundemann et al., 1998).”
InfluentialBurgdorf, C., Dendorfer, A., Kurz, T., Schömig, E., Stölting, I., Schütte, F., & Richardt, G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059832 · Cited by 28
“Recently, molecular identification of the extraneuronal monoamine transporter (EMT, uptake2) has been reported (Gründemann et al., 1998; Gründemann and Schömig, 2000).”
BackgroundSelf-citationActivation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells
Gründemann, D., Koschker, A., Haag, C., Honold, C., Zimmermann, T., & Schömig, E. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704926 · Cited by 28
Self-citationUptake of Pramipexole by Human Organic Cation Transporters
Diao, L., Shu, Y., & Polli, J. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100036b · Cited by 28
Expression and functional characterization of choline transporter in human keratinocytes.
Uchida, Y., Inazu, M., Takeda, H., Yamada, T., Tajima, H., & Matsumiya, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08291fp · Cited by 27
Faria, A., Mateus, N., de Freitas, V., & Calhau, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.11.068 · Cited by 27
“domain and four in intracellular domains [26].”
Orrico‐Sánchez, A., Chausset‐Boissarie, L., de Sousa, R. A., Coutens, B., Amin, S. R., Vialou, V., Louis, F., Hessani, A., Dansette, P. M., Zornoza, T., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0548-4 · Cited by 33
“D24 is a potent and relatively selective OCT inhibitor, interacting with a putative high-affinity binding site of these transporters [16] and affinity constants ranging from 15 to 280 nM for brain OCT [17, 18].”
BackgroundMcReynolds, J. R., Taylor, A., Vranjkovic, O., Ambrosius, T., Derricks, O., Nino, B., Kurtoglu, B., Wheeler, R. A., Baker, D. L., Gasser, P. J., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.187 · Cited by 29
Holleran, K. M., Rose, J. H., Fordahl, S., Benton, K. C., Rohr, K. E., Gasser, P., & Jones, S. R. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14927 · Cited by 25
Identification of genes directly responding to DLK1 signaling in Callipyge sheep
Yu, H. M., Waddell, J. N., Kuang, S., Tellam, R. L., Cockett, N., & Bidwell, C. A. (2018) · BMC Genomics · doi:10.1186/s12864-018-4682-1 · Cited by 24
Metadata
- Authors
- Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E.
- Affiliations
- Heidelberg University (DE)
- Corresponding author
- Gründemann, Dirk
- Venue
- Nature Neuroscience
- Published
- 1998-09
- Volume
- 1
- Issue
- 5
- Pages
- 349-351
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- DOI
- 10.1038/1557
- OpenAlex
- W1493374490
- Cited by
- 374
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 11 · 2018: 9 · 2017: 8 · 2016: 16 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 13
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- sympathetic innervation, pharmacological characterization
- MeSH terms
- Organic Cation Transporter 3, Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 6, Corticosterone, Humans, Kinetics, Molecular Sequence Data, Myocardium, Norepinephrine, 1-Methyl-4-phenylpyridinium, Organic Cation Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review